CYSD2 Antibody

Shipped with Ice Packs
In Stock

Description

Potential Explanations for the Absence of CYSD2 Antibody Data

The lack of information on CYSD2 Antibody may stem from the following:

  • Nomenclature Variability: The antibody might be referred to by an alternative name (e.g., a target protein or gene symbol). For example, "CYSD2" could correspond to a gene encoding an antigen, but no antibody specific to this target is documented in the provided sources.

  • Novel or Experimental Status: CYSD2 Antibody may be under development in preclinical studies, with data not yet published or indexed in public databases.

  • Typographical Error: The name might be misspelled or misinterpreted (e.g., confusion with similar-sounding targets like "CYP" or "CSD" antibodies).

General Antibody Research Context

While CYSD2 Antibody is not explicitly mentioned, the search results provide insights into antibody development and mechanisms that could inform its potential characteristics:

FeatureExample AntibodiesKey Findings
StructureIgG, Fab, CDR H3 knobsUltralong CDR H3 regions in bovine antibodies enable neutralization of SARS-CoV-2 variants .
FunctionNeutralization, OpsonizationAntibodies activate complement systems and facilitate phagocytosis .
Class SwitchingIgM → IgG/IgA/IgEClass switching allows isotype diversification for tailored immune responses .
Therapeutic ApplicationsREGN10987, S309Broadly neutralizing antibodies target SARS-CoV-2 spike protein epitopes .

Recommendations for Further Investigation

To locate information on CYSD2 Antibody, consider the following steps:

  1. Verify Nomenclature:

    • Cross-check the target antigen (e.g., "CYSD2" as a gene/protein).

    • Explore synonyms or related terms (e.g., "Cysteine-rich domain-containing protein" or "CysD2").

  2. Expand Literature Search:

    • Query PubMed, ClinicalTrials.gov, and Antibody Society databases with refined keywords.

    • Search preprint repositories (e.g., bioRxiv, medRxiv) for unpublished studies.

  3. Consult Commercial Databases:

    • Platforms like AntibodyFinder or Biocompare may list proprietary antibodies not indexed in academic sources.

Hypothetical Characteristics of CYSD2 Antibody

If CYSD2 Antibody were a novel therapeutic, its properties might align with trends in antibody research:

PropertyPotential Profile
TargetA cysteine-rich protein (e.g., involved in viral entry, immune regulation).
IsotypeIgG (common for systemic therapies) or IgA (mucosal applications).
MechanismNeutralization, ADCC, or complement activation.
Development StagePreclinical (e.g., tested in vitro/in vivo models) or early-phase clinical trials.

Critical Analysis of Antibody Development

The absence of CYSD2 Antibody data underscores challenges in antibody research, including:

  • Epistatic Interactions: Mutations in viral targets (e.g., SARS-CoV-2) can evade antibody binding through complex interactions .

  • Class-Specific Efficacy: Isotype choice (e.g., IgG vs. IgM) impacts neutralization potency and tissue penetration .

  • Structural Complexity: Ultralong CDR H3 regions in bovine antibodies highlight the importance of structural innovation in targeting "hidden" epitopes .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
CYSD2 antibody; OAS6 antibody; At5g28020 antibody; F15F15.90 antibody; Bifunctional L-3-cyanoalanine synthase/cysteine synthase D2 antibody; EC 2.5.1.47 antibody; EC 4.4.1.9 antibody; Beta-substituted Ala synthase 4;2 antibody; ARAth-Bsas4;2 antibody; Cysteine synthase D2 antibody; AtcysD2 antibody; O-acetylserine antibody; thiol)-lyase 6 antibody
Target Names
CYSD2
Uniprot No.

Target Background

Function
CYSD2 antibody functions as a cysteine synthase. This antibody exhibits a higher efficiency in the cysteine synthesis reaction compared to its cyanoalanine synthase activity.
Database Links

KEGG: ath:AT5G28020

STRING: 3702.AT5G28020.1

UniGene: At.23896

Protein Families
Cysteine synthase/cystathionine beta-synthase family
Subcellular Location
Cytoplasm.
Tissue Specificity
Predominantly expressed in leaves and flowers.

Q&A

What is a Cy2-conjugated antibody and how does it function in immunodetection?

Cy2-conjugated antibodies are immunoglobulins labeled with the Cy2 fluorescent dye, which enables visualization of target antigens in various immunodetection techniques. These antibodies consist of whole IgG molecules isolated from antisera through immunoaffinity chromatography. The antibody structure includes an Fc portion and two antigen-binding Fab portions connected by disulfide bonds, making them divalent with an average molecular weight of approximately 160 kDa. This whole IgG format is preferred for most immunodetection procedures due to its cost-effectiveness and versatility .

Functionally, when these antibodies bind to their target antigens, the attached Cy2 fluorophore can be excited at 492 nm, emitting green fluorescence with a peak at approximately 510 nm. This optical property allows researchers to visualize the antigen-antibody binding events using fluorescence microscopy or other detection systems, thereby enabling localization and semi-quantitative analysis of specific proteins within biological samples .

What are the recommended storage and handling protocols for Cy2-conjugated antibodies?

Proper storage and handling of Cy2-conjugated antibodies are critical for maintaining their functionality. For lyophilized (freeze-dried) antibodies, store the solid at 2-8°C in a dark environment to prevent photobleaching of the fluorophore. When rehydrating these antibodies, use the specified volume of distilled water according to the product specification sheet, and centrifuge if the solution isn't completely clear .

For short-term storage of rehydrated antibodies (up to 6 weeks), keep the undiluted liquid at 2-8°C in a dark container. For extended storage, two options are recommended: (1) aliquot the antibody solution and freeze at -70°C or below, avoiding repeated freeze-thaw cycles that can damage antibody structure and function; or (2) add an equal volume of high-quality glycerol (ACS grade or better) to achieve a final concentration of 50%, then store at -20°C as a liquid .

Working dilutions should be prepared on the day of use and not stored for extended periods to ensure optimal performance. The expiration date for rehydrated antibodies is typically one year from the rehydration date, though this may be extended if experimental validation confirms acceptable performance for the intended application .

How should Cy2-conjugated antibodies be diluted for various immunodetection applications?

The appropriate dilution must be determined empirically for each experimental setup. This typically involves testing a range of dilutions in preliminary experiments to identify the concentration that provides the optimal signal-to-noise ratio for the specific application. For immunofluorescence applications, begin with a middle-range dilution (e.g., 1:100) and adjust based on signal intensity and background levels .

When optimizing dilutions, researchers should consider:

  • The abundance of the target protein

  • The affinity of the antibody for its target

  • Sample preparation methods (fixation, permeabilization)

  • The sensitivity of the detection system

  • The potential for cross-reactivity with non-target proteins

Testing multiple dilutions in parallel with appropriate positive and negative controls is the most reliable approach to determining the optimal working concentration for each specific experimental context .

What spectral properties characterize Cy2 and how do they compare to other fluorescent dyes?

Cy2 is a green-fluorescing cyanine dye with maximum absorption/excitation at 492 nm and an emission peak around 510 nm. These spectral characteristics place Cy2 in the green region of the visible spectrum, similar to FITC which has an emission peak at approximately 520 nm .

Although Cy2 and FITC occupy similar spectral regions, Cy2 offers certain advantages, including greater photostability and reduced sensitivity to pH changes compared to FITC. This makes Cy2 more suitable for experiments requiring extended imaging periods or those conducted under varying pH conditions .

These spectral and performance characteristics should be carefully considered when designing multicolor immunofluorescence experiments to ensure optimal signal separation and detection sensitivity.

Why is knockout validation important for antibody characterization?

Knockout (KO) validation represents a gold standard approach for antibody characterization and is particularly valuable for assessing antibody specificity. This method involves testing antibodies on samples derived from cells or organisms where the target gene has been deleted or inactivated. The absence of signal in KO samples provides compelling evidence for antibody specificity, as any detected signal in these samples would indicate off-target binding .

Research has demonstrated that genetic validation approaches, particularly those using KO controls, consistently outperform orthogonal validation strategies. In a comprehensive study evaluating 614 commercial antibodies targeting 65 neuroscience-related proteins, antibodies validated using genetic approaches showed significantly higher confirmation rates (89% for Western blotting and 80% for immunofluorescence) compared to those validated through orthogonal approaches .

For researchers, this emphasizes the importance of selecting antibodies validated through KO testing when available. When publishing research utilizing antibodies including Cy2-conjugated ones, researchers should prioritize antibodies validated against KO controls and should clearly document validation methodologies to enhance experimental reproducibility .

How can researchers systematically validate Cy2-conjugated antibodies for experimental applications?

Systematic validation of Cy2-conjugated antibodies requires a comprehensive approach testing multiple parameters across different applications. Based on large-scale antibody characterization initiatives, a standardized validation workflow is recommended:

  • Western Blotting (WB) Validation: Test antibodies on cell lysates for intracellular proteins or cell media for secreted proteins. Compare results between parental cell lines and matched knockout (KO) lines to evaluate specificity. A specific antibody should show bands of the expected molecular weight in the parental line that are absent in the KO samples .

  • Immunoprecipitation (IP) Validation: For antibodies intended for IP applications, test on non-denaturing cell lysates (for intracellular proteins) or cell media (for secreted proteins). Evaluate immunocapture efficiency by subsequent WB analysis using a previously validated antibody. Comparing IP efficiency between parental and KO samples allows assessment of both sensitivity and specificity .

  • Immunofluorescence (IF) Validation: Implement a mosaic approach that images parental and KO cells in the same visual field to reduce imaging and analysis biases. This approach is particularly powerful as it provides direct side-by-side comparison under identical experimental conditions .

For each validation experiment, detailed documentation should include:

  • Sample preparation methods

  • Antibody dilutions tested

  • Exposure times (for WB and IF)

  • All positive and negative controls

  • Raw unedited images alongside processed ones

Comprehensive validation data should be shared through open-access repositories like ZENODO to improve transparency and reproducibility in the research community .

What are the limitations of Cy2-conjugated antibodies when used with specific mounting media?

Cy2-conjugated antibodies exhibit significant limitations when used with certain aqueous mounting media, particularly those containing p-phenylenediamine as an anti-fading agent. This interaction results in weak and diffuse fluorescent signals that can dramatically reduce detection sensitivity and image quality .

The chemical interaction between Cy2 and p-phenylenediamine alters the fluorophore's spectral properties, leading to substantial signal attenuation. This effect is specific to Cy2 and is not observed to the same extent with newer fluorophores such as Alexa Fluor 488 .

To address this limitation, researchers should:

  • Consider using Alexa Fluor 488 as an alternative for experiments requiring aqueous mounting media, as it provides superior brightness and photostability compared to Cy2, FITC, and DyLight 488 .

  • If Cy2-conjugated antibodies must be used, select mounting media specifically formulated without p-phenylenediamine, though this may reduce protection against photobleaching.

  • For long-term sample storage, consider using hardening mounting media compatible with Cy2 if the experimental setup allows.

  • Optimize image acquisition parameters to maximize signal detection while minimizing exposure time to reduce photobleaching effects.

Understanding these technical limitations is crucial for experimental design, particularly for quantitative fluorescence applications where signal intensity correlates with protein abundance .

How does antibody performance correlation between different applications inform experimental design?

Analysis of large-scale antibody validation studies reveals important correlations between antibody performance across different applications, which can guide experimental design decisions. Research examining hundreds of antibodies against dozens of protein targets has established that:

  • Immunofluorescence (IF) performance predicts Western blot (WB) and immunoprecipitation (IP) success: Antibodies that perform well in IF applications have a high probability of also succeeding in WB and IP applications. This suggests that IF validation might serve as an efficient initial screening method when developing experimental workflows .

  • Cross-application performance is not uniformly bidirectional: While IF success strongly predicts WB performance, the reverse correlation is weaker. Many antibodies that work for WB may fail in IF applications due to differences in epitope accessibility under the different sample preparation methods .

  • Validation methodology affects cross-application reliability: Antibodies validated using knockout strategies rather than orthogonal approaches show more consistent performance across different applications .

This correlation data has significant implications for experimental planning:

  • When developing multi-technique workflows, start by identifying antibodies validated for the most stringent application (typically IF)

  • For critical experiments, perform validation in the specific application of interest rather than assuming cross-application performance

  • Prioritize antibodies validated using genetic approaches (knockout controls) as they demonstrate higher success rates across multiple applications

Understanding these performance correlations can save significant time and resources in experimental optimization while improving data reliability and reproducibility.

What strategies can improve signal-to-noise ratio when using Cy2-conjugated antibodies in immunofluorescence?

Optimizing signal-to-noise ratio for Cy2-conjugated antibodies requires addressing several technical aspects of the immunofluorescence workflow:

  • Sample Fixation and Permeabilization: The choice of fixation method significantly impacts epitope accessibility and background fluorescence. For Cy2-conjugated antibodies, paraformaldehyde fixation (4%, 10-15 minutes) followed by controlled permeabilization (0.1-0.2% Triton X-100 for 5-10 minutes) often provides a good balance between structural preservation and antibody accessibility.

  • Blocking Protocol Optimization: Extend blocking steps (using 3-5% BSA or 5-10% serum from the species of the secondary antibody) to 1-2 hours at room temperature or overnight at 4°C to minimize non-specific binding of Cy2-conjugated antibodies.

  • Titrate Primary and Secondary Antibodies: Despite manufacturer recommendations of 1:50-1:200 dilutions, optimal concentrations should be determined empirically for each experimental system. Testing a dilution series (e.g., 1:50, 1:100, 1:200, 1:500) can identify the concentration providing maximum specific signal with minimal background .

  • Implement Stringent Washing: Increase wash duration and volume between antibody incubations, using PBS with 0.1% Tween-20 to reduce non-specific binding. Consider 5-6 washes of 5-10 minutes each after both primary and secondary antibody incubations.

  • Select Compatible Mounting Media: Given Cy2's sensitivity to p-phenylenediamine, choose mounting media specifically formulated for this fluorophore or consider alternatives like Alexa Fluor 488 for experiments requiring antifade reagents .

  • Optimize Image Acquisition Parameters: Adjust exposure times, gain, and offset settings during microscopy to maximize specific signal while minimizing background and autofluorescence.

  • Consider Counterstaining Strategy: When using nuclear counterstains (DAPI/Hoechst), ensure their spectral properties don't interfere with Cy2 detection by adjusting concentrations and acquisition settings accordingly.

Implementing these strategies systematically while maintaining appropriate controls will significantly improve signal-to-noise ratios when working with Cy2-conjugated antibodies.

How should knockout controls be implemented for rigorous antibody validation?

Knockout (KO) controls represent the gold standard for antibody validation, providing definitive evidence of specificity. To implement KO controls effectively for Cy2-conjugated antibody validation:

  • Generate appropriate KO cell lines: For optimal validation, create KO lines in cells that endogenously express the target protein at detectable levels. CRISPR-Cas9 technology allows relatively straightforward generation of targeted knockouts. When validating antibodies against essential genes, knockdown approaches may be substituted .

  • Implement mosaic imaging approaches: For immunofluorescence validation, a powerful strategy involves creating a cellular mosaic where parental and KO cells are mixed and imaged in the same field of view. This approach eliminates imaging and analysis biases by ensuring identical experimental conditions for both cell types .

  • Establish rigorous validation criteria: A specific antibody should show:

    • For WB: Bands of the expected molecular weight in parental cells that are absent in KO cells

    • For IF: Clear staining in parental cells with complete absence of signal in KO cells within the same field

    • For IP: Specific immunocapture from parental cells but not from KO cells

  • Document and share validation data: All validation experiments should be documented comprehensively, including raw unedited images, and shared through open repositories such as ZENODO, as implemented by initiatives like Antibody Characterization through Open Science (YCharOS) .

  • Incorporate validation data into research protocols: When publishing research using Cy2-conjugated antibodies, include validation methodologies and results, preferably with references to publicly accessible validation data.

The scientific community should prioritize the creation of a biobank containing KO cell lines for each human gene to facilitate widespread rigorous antibody validation, as current limitations in KO line availability represent a significant barrier to large-scale production of validated antibodies .

What factors contribute to weak fluorescent signals when using Cy2-conjugated antibodies?

When encountering weak fluorescent signals with Cy2-conjugated antibodies, several factors should be systematically investigated:

  • Incompatible mounting media: Cy2 fluorescence is particularly sensitive to p-phenylenediamine, a common anti-fading agent in mounting media. This interaction results in weak and diffuse signals. Switching to compatible mounting media can dramatically improve signal intensity .

  • Photobleaching: While Cy2 offers improved photostability compared to FITC, it is still susceptible to photobleaching during prolonged exposure. Minimize sample exposure to excitation light during preparation and observation. Consider using antifade reagents compatible with Cy2 or switching to more photostable alternatives like Alexa Fluor 488 for applications requiring extended imaging sessions .

  • Suboptimal storage conditions: Fluorescent antibodies are susceptible to degradation if improperly stored. Ensure Cy2-conjugated antibodies are stored according to manufacturer recommendations (typically aliquoted and stored at -70°C or in 50% glycerol at -20°C) and protected from light. Using antibodies past their expiration date or those subjected to multiple freeze-thaw cycles may result in signal degradation .

  • Insufficient antibody concentration: The recommended dilution range of 1:50-1:200 may not be optimal for all experimental conditions. Empirically testing higher concentrations while monitoring background levels may reveal the optimal working dilution for specific applications .

  • Epitope masking during fixation: Certain fixation methods may mask epitopes recognized by the primary antibody. Consider alternative fixation protocols or implement antigen retrieval techniques if appropriate for the sample type.

Methodically addressing these factors through controlled experiments can significantly improve signal intensity when working with Cy2-conjugated antibodies.

How does antibody validation methodology affect experimental reproducibility?

The validation methodology used for antibodies, including Cy2-conjugated antibodies, significantly impacts experimental reproducibility. Analysis of validation approaches reveals critical insights for researchers:

  • Validation strategy efficacy varies by application: Large-scale studies have shown that while orthogonal validation approaches (which rely on known information about target proteins) achieve reasonable success rates for Western blotting (80%), they perform poorly for immunofluorescence applications (38% confirmation rate). In contrast, genetic validation strategies using knockout controls yield much higher confirmation rates (89% for WB, 80% for IF) .

  • Publication practices often lack validation information: Despite the importance of antibody validation, a significant percentage of published studies fail to provide adequate information about antibody characterization methods. This contributes to reproducibility challenges across the research community .

  • Validation data availability improves experimental design: Access to comprehensive validation data through open platforms (like ZENODO or the Antibody Registry) allows researchers to make informed decisions about antibody selection and experimental design. Initiatives such as YCharOS and partnerships with resources like the RRID Portal Community are working to improve dissemination of validation data .

To improve experimental reproducibility when using Cy2-conjugated antibodies:

  • Prioritize antibodies validated using genetic approaches (knockout controls)

  • Implement validation in your specific experimental system before conducting critical experiments

  • Document and share validation methods and results in publications

  • Utilize open-access resources that aggregate antibody validation data

  • Consider contributing validation data to community resources when working with novel or poorly characterized antibodies

These practices collectively enhance the reliability and reproducibility of experiments using Cy2-conjugated antibodies across the research community .

What alternative fluorophores might provide advantages over Cy2 for certain applications?

While Cy2 offers certain advantages over traditional fluorophores like FITC, newer alternatives may provide superior performance for specific applications. Researchers should consider these alternatives when designing experiments:

  • Alexa Fluor 488: This fluorophore is specifically recommended as the preferred green-fluorescing dye for applications requiring aqueous mounting media. Compared to Cy2, Alexa Fluor 488 provides:

    • Greater brightness and photostability

    • Compatibility with p-phenylenediamine-containing mounting media

    • Less sensitivity to environmental conditions like pH
      These properties make Alexa Fluor 488 particularly advantageous for quantitative imaging applications and experiments requiring extended imaging sessions .

  • DyLight 488: While mentioned as less optimal than Alexa Fluor 488, DyLight 488 still offers some advantages over Cy2, particularly for applications requiring higher photostability .

  • Other cyanine dyes: For multiplexed imaging requiring spectrally distinct fluorophores, other members of the cyanine dye family (Cy3, Cy5, Cy7) can be paired with alternative green fluorophores to achieve optimal spectral separation.

Selection criteria for choosing between Cy2 and alternative fluorophores should include:

  • Mounting media compatibility requirements

  • Need for quantitative analysis

  • Imaging duration (photobleaching considerations)

  • Multiplexing requirements

  • Budget constraints (newer fluorophores typically cost more)

  • Availability of validated antibodies with the desired conjugation

For most cutting-edge applications requiring green fluorescence detection, particularly in immunofluorescence with aqueous mounting media, Alexa Fluor 488 represents the current gold standard alternative to Cy2 .

Comparative Properties of Common Green Fluorescent Dyes

PropertyCy2FITCAlexa Fluor 488DyLight 488
Excitation Maximum492 nm495 nm495 nm493 nm
Emission Maximum510 nm520 nm519 nm518 nm
Relative BrightnessModerateModerateHighModerate-High
PhotostabilityBetter than FITCPoorExcellentGood
pH SensitivityModerateHighLowLow
Compatible with p-phenylenediamineNoYesYesPartial
Recommended for Aqueous MountingNoLimitedYesLimited
Relative CostModerateLowHighModerate-High

This table summarizes the key spectral and performance characteristics of Cy2 compared to alternative green fluorescent dyes based on information from the search results .

Antibody Validation Success Rates by Methodology and Application

Validation ApproachWestern Blot Success RateImmunofluorescence Success Rate
Orthogonal Strategies80%38%
Genetic Strategies (KO/KD)89%80%
Other ApproachesVariesVaries

This table highlights the differential success rates of antibody validation methodologies across applications, emphasizing the superior performance of genetic validation strategies, particularly for immunofluorescence applications .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.